Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Acorda Therapeutics Inc    ACOR

Delayed Quote. Delayed  - 05/27 09:59:59 pm
27.29 USD   +1.53%
05/20DJACORDA THERAPEU : to Discontinue Epilepsy Drug Development
05/20 ACORDA THERAPEU : to Discontinue Development of PLUMIAZ for Treatmen..
05/18 ACORDA THERAPEU : Biotie Therapies Corp. to Delist Its American Depo..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/23/2016 05/24/2016 05/25/2016 05/26/2016 05/27/2016 Date
26.65(c) 27.59(c) 27.21(c) 26.88(c) 27.29(c) Last
604 494 554 587 425 892 563 416 810 924 Volume
+1.29% +3.53% -1.38% -1.21% +1.53% Change
More quotes
Financials ($)
Sales 2016 515 M
EBIT 2016 5,30 M
Net income 2016 -10,6 M
Debt 2016 81,2 M
Yield 2016 -
Sales 2017 571 M
EBIT 2017 48,5 M
Net income 2017 -3,34 M
Debt 2017 97,1 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales 2016 2,60x
EV / Sales 2017 2,37x
Capitalization 1 257 M
More Financials
Company
Acorda Therapeutics, Inc. develops and markets therapeutic products for nervous system disorders.The company's two main products are Ampyra and Zanaflex Capsules.The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex Capsules, which is a short... 
More about the company
Surperformance© ratings of Acorda Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ACORDA THERAPEUTICS INC
05/20DJACORDA THERAPEUTICS : to Discontinue Epilepsy Drug Development
05/20 ACORDA THERAPEUTICS INC : Other Events, Financial Statements and Exhibits (form ..
05/20 ACORDA THERAPEUTICS : to Discontinue Development of PLUMIAZ for Treatment of Epi..
05/18 ACORDA THERAPEUTICS : Biotie Therapies Corp. to Delist Its American Depositary S..
05/18 ACORDA THERAPEUTICS : Biotie therapies corp. cancels all treasury shares held by..
05/18 ACORDA THERAPEUTICS : Biotie therapies corp. to delist its american depositary s..
05/12 ACORDA THERAPEUTICS : Named One of the Best Places to Work for in New York
05/12 ACORDA THERAPEUTICS : Patent Issued for Methods for Detecting Cardiac Damage (US..
05/12 ACORDA THERAPEUTICS : to Present at Two Investor Conferences in May
05/04 ACORDA THERAPEUTICS : Named One of the Best Places to Work for in New York
More news
Sector news : Bio Therapeutic Drugs
05/30 Genmab Achieves USD 30 Million Milestone in DARZALEX(r) (daratumumab) Collabo..
05/30 GENMAB A/S : Achieves USD 30 Million Milestone in DARZALEX® (daratumumab) Collab..
05/30 Samsung Bioepis receives final European approval for its Remicade copy
05/27 AMGEN : receives positive CHMP opinion to extend indication of Kyprolis
05/27 Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Pos..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
05/23 BIOTECH FORUM DAILY DIGEST : Can Biotech Rally For The Second Week In A Row? New..
05/20 Acorda bags development of PLUMIAZ for epilepsy seizures after lagging Diasta..
05/15 Tracking Seth Klarman's Baupost Group Holdings - Q1 2016 Update
04/28 Acorda Therapeutics (ACOR) Q1 2016 Results - Earnings Call Webcast
04/28 Acorda Therapeutics misses by $0.01, beats on revenue
Advertisement
Chart ACORDA THERAPEUTICS INC
Duration : Period :
Acorda Therapeutics Inc Technical Analysis Chart | ACOR | US00484M1062 | 4-Traders
Full-screen chart
Technical analysis trends ACORDA THERAPEUTI...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions